Trip.com Up Over 7%, on Track for Record High Close — Data Talk
Trip.com Group Ltd. Sponsored ADR (TCOM) is currently at $60.98, up $4.31 or 7.6%
--Would be new all-time high (Based on available data back to Dec. 9, 2003)
--Would be the first record close since July 31, 2017, when it closed at $59.73
--Currently up seven of the past eight days
--Currently up two consecutive days; up 19.39% over this period
--Best two day stretch since the two days ending March 17, 2022, when it rose 22.72%
--Up 29.37% month-to-date; on pace for best month since Nov. 2022, when it rose 41.18%
--Up 69.36% year-to-date
--Up 74.39% from 52 weeks ago (Sept. 29, 2023), when it closed at $34.97
--Would be a new 52-week closing high
--Up 90.04% from its 52-week closing low of $32.09 on Oct. 20, 2023
--Traded as high as $61.08; new all-time intraday high (Based on available data back to Dec. 9, 2003)
--Up 7.77% at today's intraday high
All data as of 12:46:35 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2024 13:04 ET (17:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks